Table 1.
Therapeutic studies of bromelain based on experimental studies.
Fields of Study | Subjects | Dosage | Outcomes | References |
---|---|---|---|---|
Anti-inflammatory | Rats | 10 and 20 mg/kg | Large reduction in exudate concentrations of both substance P and PGE2 | [60] |
Antimicrobial Activity | Streptococcus mutans , Enterococcus fecalis, Aggregatibacteractinomycetemcomitans (Aa), and Porphyromonasgingivalis | Minimum inhibitory concentration (MIC) of bromelain | S. mutans showed sensitivity at the lowest concentration of 2 mg/mL as compared to E. fecalis (31.25 mg/mL), while Pgingivalis showed sensitivity at the lowest concentration of 4.15 mg/mL as compared to Aa (16.6 mg/mL) | [128] |
Antibiotic Potentiation | Rabbits | 20–25mg/kg | Intramuscular and intraduodenal administration of bromelain enhanced penicillin-content of the cerebrospinal fluid, which normallyis much lower than in serum | [129,130] |
Hepatic Microcirculation | 140 Rats | 0.1, 1.0, or 10 mg/kg | Increased leukocyte adherence, apoptosis rate, Kupffer cell activation, and endothelial cell damage, AST and ALT levels were significantly increased, improved microcirculation, increased eNOS expression | [131] |
Anti-ulcer activity | Rats | 200 ng/kg | Ulcer index and total acidity level were significantly reduced. | [111] |
Anti-tumoral activity | Mice | 12.5 and 25 mg/kg | Significantly decreased the amount of lung metastasis used by LLC transplantation | [46] |
Anthelmintic efficacy | Haemonchus contortus | 150 μM concentration | Important adulticidal action on Haemonchus contortus to destroy all worms, damage their cuticle after 8 h of incubation, and eventually cause worms to disintegrate | [105] |
Female CD1 mice | Different concentrations | Decreased amount of Heligmosomoides polygyrus | [132] | |
Chickens | 1008 mg/kg, 504 mg/kg, 255 mg/kg | Total worm count was significantly decreased | [133] | |
Mice | 0.2 mL containing 240 nmol stem bromelain | 24.5% reduction in worm burdens | [134] | |
Anti-rheumatic activity | Rats | 50, 100, 250 and 500 mg/kg | Significantly reduced the swelling in the paw of rats | [135] |
Antinociceptive | 48 Wistar rats | 30 mg/kg and 50 mg/kg | The thermal hyperalgesia and allodynic mechanical indices of neuropathic pain were greatly reduced by bromelain | [75] |
Immunomodulatory | Mice | 200 mg/mL | Bromelain improved T-cell-dependent, Ag-specific, B cell antibody responses | [63] |
Anti-platelet Activity | Rats | 1, 5, 10, 20, and 30 mg/kg | Blood coagulation was delayed significantly | [17,130] |